LIPOCINE INC. Repayments of Debt
LIPOCINE INC. (LPCN) reported Repayments of Debt of $1.67 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2024-03-07
- LIPOCINE INC. repayments of debt for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- LIPOCINE INC. repayments of debt for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- LIPOCINE INC. repayments of debt for the quarter ending 2022-06-30 was $833.33K, a 0.00% decline year-over-year.
- LIPOCINE INC. repayments of debt for the quarter ending 2022-03-31 was $833.33K, a 0.00% increase year-over-year.
- LIPOCINE INC. repayments of debt for fiscal 2022 was $1.67M, a 50.00% decline from fiscal 2021.
- LIPOCINE INC. repayments of debt for fiscal 2021 was $3.33M, a 100.00% increase from fiscal 2020.
- LIPOCINE INC. repayments of debt for fiscal 2020 was $1.67M, a 50.00% decline from fiscal 2019.
- LIPOCINE INC. repayments of debt for fiscal 2019 was $3.33M.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $0.00 derived: sum of 2 quarters · filed 2024-03-07 | $833.33K derived: sum of 3 quarters · filed 2024-03-07 | $1.67M 10-K · filed 2024-03-07 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $833.33K derived: sum of 2 quarters · filed 2023-11-08 | $1.67M 10-Q · filed 2023-11-08 | $2.50M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $833.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.67M 10-Q · filed 2023-08-10 | $2.50M derived: sum of 3 quarters · filed 2023-08-10 | $3.33M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $833.33K 10-Q · filed 2023-05-11 | $1.67M derived: sum of 2 quarters · filed 2023-05-11 | $2.50M derived: sum of 3 quarters · filed 2023-05-11 | $3.33M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $833.33K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $1.67M derived: sum of 2 quarters · filed 2023-03-10 | $2.50M derived: sum of 3 quarters · filed 2023-03-10 | $3.33M 10-K · filed 2023-03-10 |
| 2021-09-30 | $833.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.67M derived: sum of 2 quarters · filed 2022-11-09 | $2.50M 10-Q · filed 2022-11-09 | $3.06M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $833.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.67M 10-Q · filed 2022-08-08 | $2.22M derived: sum of 3 quarters · filed 2022-08-08 | $2.22M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $833.33K 10-Q · filed 2022-05-09 | $1.39M derived: sum of 2 quarters · filed 2022-05-09 | $1.39M derived: sum of 3 quarters · filed 2022-05-09 | $1.67M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $555.56K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $555.56K derived: sum of 2 quarters · filed 2022-03-09 | $833.33K derived: sum of 3 quarters · filed 2022-03-09 | $1.67M 10-K · filed 2022-03-09 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $277.78K derived: sum of 2 quarters · filed 2021-11-10 | $1.11M 10-Q · filed 2021-11-10 | $1.94M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $277.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.11M 10-Q · filed 2021-08-05 | $1.94M derived: sum of 3 quarters · filed 2021-08-05 | $2.78M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $833.33K 10-Q · filed 2021-05-06 | $1.67M derived: sum of 2 quarters · filed 2021-05-06 | $2.50M derived: sum of 3 quarters · filed 2021-05-06 | $3.33M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $833.33K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $1.67M derived: sum of 2 quarters · filed 2021-03-11 | $2.50M derived: sum of 3 quarters · filed 2021-03-11 | $3.33M 10-K · filed 2021-03-11 |
| 2019-09-30 | $833.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $1.67M derived: sum of 2 quarters · filed 2020-11-10 | $2.50M 10-Q · filed 2020-11-10 | $2.50M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $833.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.67M 10-Q · filed 2020-08-06 | $1.67M derived: sum of 3 quarters · filed 2020-08-06 | |
| 2019-03-31 | $833.33K 10-Q · filed 2020-05-07 | $833.33K derived: sum of 2 quarters · filed 2020-05-07 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $0.00 10-K · filed 2020-03-13 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |